Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis

• Published in: The journal of clinical psychiatry Vol. 73; no. 1; p. 95
• Main Authors: Weiner, Elaine, Ball, M Patricia, Buchholz, Alison S, Gold, James M, Evins, A Eden, McMahon, Robert P, Buchanan, Robert W
• Format: Journal Article
• Language: English
• Published: United States 01.01.2012
• Subjects: Antidepressive Agents, Second-Generation - administration & dosage; Antidepressive Agents, Second-Generation - adverse effects; Antidepressive Agents, Second-Generation - therapeutic use; Bupropion - administration & dosage; Bupropion - adverse effects; Bupropion - therapeutic use; Combined Modality Therapy - methods; Combined Modality Therapy - psychology; Combined Modality Therapy - statistics & numerical data; Delayed-Action Preparations - therapeutic use; Double-Blind Method; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic - statistics & numerical data; Schizophrenic Psychology; Self-Help Groups - statistics & numerical data; Smoking - drug therapy; Smoking - therapy; Smoking Cessation - methods
• ISSN: 1555-2101
• DOI: 10.4088/JCP.10m06143gre

To clarify the efficacy and tolerability of bupropion sustained release (SR) for the treatment of cigarette smoking in people with schizophrenia. The first study is a double-blind, placebo-controlled clinical trial with 32 outpatients from the Maryland Psychiatric Research Center. From May 2003 to J...